Ascent Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Ascent Group's RMD Position: Q2 2026 in Review
Ascent Group sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,366 shares — an estimated $307K sold.
Ascent Group first reported a position in RMD in Q4 2021 and held it in 18 quarters. The position peaked at $750K in Q1 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Ascent Group reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Ascent Group sold 1,366 ResMed shares in Q2 2026, an estimated $307K.
- Ascent Group first reported a position in ResMed in Q4 2021 and held it in 18 quarters.
- Ascent Group's ResMed position peaked at $750K in Q1 2023.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.